CLINICAL_TRIALS
trial_result
· 2018-11-02
Clinical Trial Update: Open-Label Treatment Extension Study [Phase 3]
Summary
An open-label treatment extension study (Phase 3) for opioid use disorder and related disorders has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Indivior Inc. | Conditions: Opioid Use Disorder, Opioid-related Disorders | Phase 3 | Status: COMPLETED | Results posted: 2018-11-02